Barés, G.; Beà , A.; Hernández, L.; Navaridas, R.; Felip, I.; Megino, C.; Blasco, N.; Nadeu, F.; Campo, E.; Llovera, M.;
et al. ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status. Cancers 2021, 13, 3803.
https://doi.org/10.3390/cancers13153803
AMA Style
Barés G, Beà A, Hernández L, Navaridas R, Felip I, Megino C, Blasco N, Nadeu F, Campo E, Llovera M,
et al. ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status. Cancers. 2021; 13(15):3803.
https://doi.org/10.3390/cancers13153803
Chicago/Turabian Style
Barés, Gisel, Aida Beà , LuÃs Hernández, Raul Navaridas, Isidre Felip, Cristina Megino, Natividad Blasco, Ferran Nadeu, ElÃas Campo, Marta Llovera,
and et al. 2021. "ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status" Cancers 13, no. 15: 3803.
https://doi.org/10.3390/cancers13153803
APA Style
Barés, G., Beà , A., Hernández, L., Navaridas, R., Felip, I., Megino, C., Blasco, N., Nadeu, F., Campo, E., Llovera, M., Dolcet, X., & Sanchis, D.
(2021). ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status. Cancers, 13(15), 3803.
https://doi.org/10.3390/cancers13153803